All GLP-1 side effectsGLP-1 side effects•8 min read

GLP-1 Nausea: How Long It Lasts and What Helps

GLP-1 nausea is the most common side effect: 25–29% on Zepbound and 44% on Wegovy vs 8–16% on placebo. Why it happens, how long it lasts, what helps.

Clinically reviewed by Teresa Maze, RDN · Lead Clinical Advisor

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health condition. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results may vary.

Yes, nausea is a known GLP-1 side effect, and it is the most common one. On the current US labels, 25–29% of people on Zepbound and 44% of people on Wegovy 2.4 mg reported nausea, against 8% and 16% on placebo. Vomiting is less common: 8–13% on Zepbound and 24% on Wegovy.

The labels also describe the usual course. Most nausea, vomiting and diarrhea happens during dose escalation and decreases over time. Some nausea needs a call to your doctor, and that list is below. For other symptoms, see the GLP-1 side effects hub.

How To Prevent and Treat Nausea on a GLP-1

How common is GLP-1 nausea? The label numbers

From the current US prescribing information for each drug. Placebo is the comparison group in the same trials.

DrugWhat the label measuredNausea: placebo → drugVomiting: placebo → drug
Zepbound (tirzepatide)Weight-reduction Studies 1 and 2, Table 18% → 25% (5 mg) · 29% (10 mg) · 28% (15 mg)2% → 8% (5 mg) · 11% (10 mg) · 13% (15 mg)
Mounjaro (tirzepatide)Type 2 diabetes placebo pool, Table 14% → 12% (5 mg) · 15% (10 mg) · 18% (15 mg)2% → 5% (5 mg) · 5% (10 mg) · 9% (15 mg)
Wegovy (semaglutide injection)2.4 mg weight-reduction trials, Table 316% → 44%6% → 24%
Wegovy 7.2 mgTable 4 (vs 2.4 mg and placebo)13% → 35% (2.4 mg) · 39% (7.2 mg)6% → 16% (2.4 mg) · 22% (7.2 mg)
Ozempic (semaglutide)Type 2 diabetes placebo pool, Table 16.1% → 15.8% (0.5 mg) · 20.3% (1 mg)2.3% → 5% (0.5 mg) · 9.2% (1 mg)
Saxenda (liraglutide)Adult trials, Table 213.8% → 39.3%3.9% → 15.7%
Rybelsus (oral semaglutide)Type 2 diabetes placebo pool, Table 26% → 11% (7 mg) · 20% (14 mg)3% → 6% (7 mg) · 8% (14 mg)

Most people on these drugs do not report nausea, and on labels that test several doses the rate generally rises with dose (Zepbound nausea levels off above 5 mg). The labels warn that rates from different trials cannot be compared directly, so this table is not a ranking of drugs. For the full picture per drug, see Zepbound side effects, Mounjaro side effects, Wegovy side effects and Ozempic side effects.

Why does tirzepatide cause nausea?

Two mechanisms have support, and neither is fully settled in people.

  • Slower stomach emptying. Every label here says the drug delays gastric emptying. The tirzepatide labels add that the delay is largest after the first dose and diminishes over time. A stomach that empties slowly stays full longer, and a large or fatty meal sits there longer. A 2022 expert consensus links the higher rate of nausea in the first 4–5 weeks to this stronger early delay.
  • Brain signaling. GLP-1 receptors sit in brain areas that control appetite. A 2024 laboratory study found that the brain-stem neurons behind fullness and the neurons behind nausea-like aversion are separate groups. The authors suggest future drugs could target fullness with less nausea. This is early research, not a finding in patients.

How long does tirzepatide nausea last?

Across weeks: Both tirzepatide labels say most nausea, vomiting and diarrhea occurred during dose escalation and decreased over time. The Wegovy label says GI reactions were reported most often during dose escalation. The Zepbound label says its slow escalation schedule exists "to reduce the risk of gastrointestinal adverse reactions."

Per episode: The 2022 expert consensus reports that nausea is usually moderate and goes away 8 days or less after it starts, and that vomiting has been reported to clear in 1–8 days.

Across the dose week: The labels do not describe a shot-day pattern for nausea. They do give the timing of the drug level. Tirzepatide reaches its peak level a median of 24 hours after the injection (range 8 to 72 hours). Semaglutide peaks 1 to 3 days after the dose. No study has tested whether nausea tracks that peak, so whether your nausea clusters in those days is something your own log can show. You can see where you are in your week with the Zepbound half-life calculator or the Wegovy half-life calculator.

What helps with GLP-1 nausea

These steps come from the Zepbound manufacturer's side-effect page and a 2022 expert consensus on GI side effects:

  1. Eat smaller meals. Split three meals into four or more smaller ones, and eat slowly.
  2. Stop eating when you feel full. On a GLP-1, fullness arrives sooner and the stomach empties slower. The last few bites are often the ones that cause trouble.
  3. Choose bland, low-fat food. Toast, crackers, rice and plain proteins are easier. Fatty foods like butter, cheese, fried food and rich sauces stay in the stomach longest. See foods to avoid on a GLP-1 and what to eat on Zepbound.
  4. Sip fluids through the day. Take small sips of clear, cool drinks, but not so much that you feel too full. If you vomit, hydration comes first. If you are losing fluid, ask your prescriber or pharmacist whether an oral rehydration or electrolyte drink is right for you.
  5. Do not lie down right after a meal. The consensus also advises against heavy activity right after eating.
  6. Avoid strong smells and very sweet or spicy meals if they set you off.
  7. Try ginger, with realistic expectations. The consensus lists ginger root or ginger drinks among foods that may ease nausea. The NIH says the best evidence for ginger is in pregnancy nausea, not GLP-1 nausea, and that ginger can cause heartburn and stomach discomfort.
  8. Ask your prescriber about anti-nausea medication. The consensus mentions anti-nausea medicines when symptoms persist. Whether you need one, and which one, is your prescriber's decision. The same goes for a slower dose increase: the Wegovy label lets your prescriber delay a step-up if you do not tolerate a dose. Do not skip, delay or change a dose on your own.

When nausea makes eating hard, the protein calculator gives you a daily target to work back toward.

When to call your doctor or get urgent care

The labels name several serious problems that can show up as nausea or vomiting. Contact your healthcare provider promptly for any of these:

  • You cannot keep fluids down, or nausea, vomiting or diarrhea does not go away. Every label here warns that fluid loss from GI side effects can cause acute kidney injury, in some reported cases needing dialysis.
  • Severe stomach pain that does not go away, with or without vomiting, sometimes felt through to your back. This is the label warning sign of pancreatitis. The labels tell you to stop the medication and call your healthcare provider right away if this happens.
  • Pain in your upper stomach, fever, yellowing of your skin or eyes, or clay-colored stools. These are the label warning signs of gallbladder problems.
  • Severe or persistent GI symptoms of any kind. The labels list severe GI reactions as a warning. On Zepbound, 1.7–3.1% of people had a severe GI reaction, against 1% on placebo.
  • Shakiness, sweating, confusion or a fast heartbeat if you also take insulin or a sulfonylurea. These can be signs of low blood sugar, and the labels say the risk is higher with those medicines.

What to track and why

"Nausea at 6 out of 10 on days 1–2 after each shot since my last step-up, gone by day 4" gives a prescriber far more to work with than "I feel sick a lot."

In GLP AI, log nausea from the side-effect catalog with a severity from 1 to 10. Vomiting is not in the catalog, so add it as a custom symptom. Log your shots too. The estimated medication level chart then shows each entry against your point in the dose week, which shows whether your nausea follows the peak. Logging meals shows whether rough days follow large or fatty meals. Before your appointment, export the doctor report PDF with your medication history, side effects and weight, and share it yourself. The GLP-1 symptom tracker and doctor visit prep pages explain how.

GLP-1 Nausea FAQ

Is it normal to feel nauseous on a GLP-1?

Yes. Nausea is the most common side effect on the GLP-1 labels: 25–29% on Zepbound, 12–18% on Mounjaro, 44% on Wegovy 2.4 mg and 15.8–20.3% on Ozempic, against 4–16% on placebo. It is most common during dose escalation and decreases over time. Nausea that stops you keeping fluids down, or comes with severe stomach pain, is not normal and needs a call to your doctor.

How long does tirzepatide nausea last?

The Zepbound and Mounjaro labels say most nausea occurs during dose escalation and decreases over time. A 2022 expert consensus reports that a nausea episode usually goes away within 8 days. A new dose step can bring it back for a few days. If it does not settle, or keeps you from drinking, contact your prescriber.

Does Zepbound cause vomiting?

It can. On the Zepbound label, vomiting was reported by 8% of people at 5 mg, 11% at 10 mg and 13% at 15 mg, against 2% on placebo. Repeated vomiting can cause dehydration, which the label warns can lead to kidney injury, so tell your healthcare provider if it does not stop.

What helps with GLP-1 nausea fast?

Small bland, low-fat meals, stopping at the first sign of fullness, sipping clear fluids, and staying upright after eating are the first steps in the manufacturer and expert guidance. Anti-nausea medication is an option to discuss with your prescriber; do not start one, or change your GLP-1 dose, on your own.

Why is nausea worse a day or two after my shot?

The labels do not describe a shot-day pattern, but they do show the drug level peaks about 24 hours after a tirzepatide injection (range 8–72 hours) and 1–3 days after a semaglutide dose. Whether nausea follows that peak has not been studied. Logging symptoms against your shot days shows whether your pattern matches.

Sources verified 2026-10-26

  1. Zepbound prescribing information (USPI, revised 08/2026): Table 1 nausea and vomiting rates; section 6.1 "Gastrointestinal Adverse Reactions" (dose escalation); 2.1 escalation schedule; 5.2–5.5 warnings; 12.2–12.3 gastric emptying and time to peak level.
  2. Mounjaro prescribing information (USPI, revised 08/2026): Table 1 nausea and vomiting rates; section 6.1 GI adverse reactions; 12.2 gastric emptying.
  3. Wegovy prescribing information (revised 06/2026): Tables 3 and 4; section 2 dose escalation; 5.2, 5.3, 5.5, 5.6 warnings; Medication Guide symptoms of pancreatitis, gallbladder problems and dehydration.
  4. Ozempic prescribing information: Table 1; section 6.1 GI adverse reactions; 12.3 time to peak level.
  5. Saxenda prescribing information (revised 02/2026): Table 2.
  6. Rybelsus prescribing information (revised 01/2026): Table 2.
  7. Zepbound.lilly.com, Managing Possible Side Effects (manufacturer nausea tips).
  8. Gorgojo-Martínez JJ, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2022;12(1):145. Table 2 and section 4.3.
  9. Huang KP, et al. Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature. 2024;632(8025):585–593.
  10. NIH National Center for Complementary and Integrative Health, Ginger (updated February 2025).

GLP AI

Editorial

Educational content from the GLP AI team about living on a GLP-1. Clinical review is credited by name on pages a reviewer has checked. Not medical advice.

More GLP-1 side effects